Recent News

• 09.04.2025 - MBX Biosciences Doses First Participant in Phase 1 Trial of MBX 4291 for the Treatment of Obesity
• 09.04.2025 - MBX Biosciences Doses First Participant in Phase 1 Trial of MBX 4291 for the Treatment of Obesity
• 08.07.2025 - MBX Biosciences Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
• 08.07.2025 - MBX Biosciences Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
• 08.05.2025 - Uy Ear
• 08.05.2025 - Uy Ear
• 07.17.2025 - Trevor Allred
• 07.17.2025 - Trevor Allred
• 07.09.2025 - July 9, 2025 10:40 AM EDT - July 9, 2025 11:15 AM EDT : Goldman Sachs 46th Annual Global Healthcare Conference
• 07.09.2025 - July 9, 2025 10:40 AM EDT - July 9, 2025 11:15 AM EDT : Goldman Sachs 46th Annual Global Healthcare Conference

Recent Filings

• 09.04.2025 - EX-99.1 EX-99.1
• 09.04.2025 - 8-K Current report
• 08.20.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.07.2025 - 8-K Current report
• 08.07.2025 - EX-99.1 EX-99.1